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Effects of oxalate on the re-initiation of DNA synthesis in LLC- Oxalate is a metabolic end product and is excreted pri-
PK1 cells do not involve p42/44 MAP kinase activation. marily by the kidney. This organic dicarboxylate is freely
Background. Oxalate interaction with renal epithelial cells filtered at the glomerulus and undergoes bi-directionalresults in a program of events that include alterations in gene
transport in the renal tubules [1–3]. The most commonexpression, re-initiation of DNA synthesis, cell growth and apo-
pathological condition involving oxalate is the formationptosis. Our studies focused on understanding the mechanisms
involved in the oxalate-induced re-initiation of the DNA syn- of calcium oxalate stones in the kidney [4]. Besides renal
thesis. The effects of oxalate alone or in combination with epi- stone formation, oxalate deposits are associated with
dermal growth factor (EGF), platelet-derived growth factor hyperplasic thyroid glands [5], benign neoplasm of the(PDGF) and insulin were investigated to determine whether
breast [6, 7], renal cysts in acquired renal cystic disease,oxalate utilized the p42/44 mitogen activated protein (MAP)
and proliferating cells in the kidney [8, 9]. Many of thesekinase pathway, which is a common pathway used by a majority
of the mitogens. conditions are associated with aberrant cell proliferation
Methods. LLC-PK1 cells (a renal epithelial cell line of por- and cell death. Previous studies from our and other labo-
cine origin) were exposed to oxalate in the presence or absence
ratories have demonstrated that the oxalate interactionof three established growth factors, EGF, insulin and PDGF,
with renal epithelial cells results in a program of events,and of the transcription/translation inhibitors, actinomycin-D
and cycloheximide. DNA synthesis was assessed by [3H]-thymi- including immediate early gene expression, re-initiation
dine incorporation. p42/44 MAP kinase activity was assessed by of DNA synthesis, cell growth and apoptosis [10–19].
super-shift analysis as well as by immunocomplex kinase assay. Re-initiation of DNA synthesis in growth-arrested LLC-
Results. Exposure of growth-arrested LLC-PK1 cells to oxa-
PK1 cells following oxalate exposure is prototypical oflate resulted in the re-initiation of the DNA synthesis that had
the effects of mitogens. However, the specific cellularbeen abolished earlier by pretreatment with transcription/trans-
lation inhibitors. Oxalate (1 mmol/L), EGF (50 ng/mL) and in- mechanisms by which oxalate exposure to renal epithe-
sulin (100 ng/mL) stimulated DNA synthesis in growth-arrested lial cells results in a re-initiation of the DNA synthesis
LLC-PK1 cells, while PDGF (50 ng/mL) had no effect. Effects are not well delineated. Thus, the present studies investi-of EGF and oxalate on DNA synthesis were additive. In con-
gated the effects of oxalate alone or in combination withtrast, oxalate and insulin had antagonistic effects on DNA synthe-
three other growth factors—epidermal growth factorsis. Additionally, oxalate did not activate the p42/44 MAP kinase
pathway while EGF stimulated this pathway. (EGF), platelet-derived growth factor (PDGF), and in-
Conclusions. These findings demonstrate that oxalate does sulin—to determine whether oxalate utilizes the p42/44
not activate the p42/44 MAP kinase pathway, and the effects MAP kinase pathway, a common pathway utilized byof oxalate are mediated by pathways that are distinct from
several growth factors.those of EGF, PDGF and insulin.
Signal transduction via mitogen-activated protein
(MAP) kinases plays a key role in growth factor induced
proliferation, differentiation and cell death [20–24]. Sev-
eral parallel MAP kinase signal transduction pathways
have been defined in mammalian cells. These pathways
include the extracellular regulated kinases (ERK1/ERK2,Key words: insulin, EGF, kidney stones, nephrolithiasis, cell prolifera-
tion, apoptosis, hyperoxaluria, mitogen pathway, calcium oxalate stones. also known as p42/44 MAP kinase), c-Jun N-terminal
kinase (JNK, also known as SAPK1) and p38 MAP ki-Received for publication June 19, 2001
nases (p38/RK, also known as SAPK2). In general, p42/and in revised form September 25, 2001
Accepted for publication September 27, 2001 44 MAP kinases are primarily stimulated by mitogenic
factors [25–28], although these kinases also can be acti- 2002 by the International Society of Nephrology
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vated under certain stress conditions. The prototypical Cell culture
MAP kinases, p42/p44, are members of a ubiquitous fam- LLC-PK1 cells (American Type Culture Collection,
ily of serine/threonine kinases that are responsible for the Rockville, MD, USA) were used between passages 216
phosphorylation and activation of various transcription and 240. The cells were serially passaged in DMEM,
factors, including c-Myc and ATF2. This pathway in- supplemented with 10% FBS, penicillin (100 U/mL),
volves activation of membrane-associated tyrosine ki- streptomycin (100 g/mL) and glucose (1.0 g/L). All
nases followed by sequential activation of Ras and Raf cultures were maintained in a 5% CO2/95% air atmo-
[29, 30]. Raf activates mitogen-activated protein kinase sphere in a humidified 37C incubator.
kinase (MEK), which in turn activates p42/44 MAP ki- Where indicated, oxalate was added at a concentration
nases. of 1 mmol/L. For these experiments a 20 mmol/L stock
solution of sodium oxalate was prepared in PBS. EachLLC-PK1 cells, a line of porcine kidney epithelial with
well containing 2 mL of DMEM received 100 L of oxa-characteristics of the S1-S3 segment of proximal tubular
late solution, such that the final oxalate concentrationepithelium that is widely used as an in vitro model of
was 1 mmol/L. The media were mixed quickly to ensurerenal epithelial cells, express transport systems for oxa-
uniform distribution of the oxalate solution. All controllate and other ions [31–33]. It has been shown that LLC-
wells received equal amount of PBS without oxalate.PK1 cells are sensitive to oxalate and provide a useful
system to study the effects of oxalate on the re-initiation
Assay of the DNA synthesisof DNA synthesis, early growth responsive gene expres-
For these studies, LLC-PK1 cells were plated at a highsion, cell growth and death [10–14]. Previously we dem-
density in six-well plates and grown to confluence. Forty-onstrated that oxalate exposure to renal epithelial cells
eight hours after the last media change, cells were incu-(LLC-PK1) in culture results in the re-initiation of DNA
bated in DMEM (0.25% serum) for 12 to 18 hours assynthesis, cell proliferation and cell death depending on
described previously [11]. These quiescent cells werethe level of oxalate [10]. However, the exact signal trans-
then exposed to oxalate (1 mmol/L), EGF (50 ng/mL),duction pathways for these diverse actions of oxalate are
PDGF (50 ng/mL) or insulin (100 ng/mL) alone or innot understood.
various combinations for 24 hours except where indi-This study used LLC-PK1 cells to investigate the role
cated. During last six hours of exposure 2 to 5 Ci ofof p42/44 MAP kinases in regulating the re-initiation of
[3H]-thymidine was added per well. At the end of theDNA synthesis in response to exposure to oxalate. Our
experimental period the medium was removed, cellsfindings provide evidence that the effects of oxalate are
were washed with two changes of ice-cold phosphatemediated by signaling pathways that are distinct from
buffered saline (PBS), and trypsinized for 30 to 45 min-those of EGF, PDGF and insulin. We also show that p42/
utes at 37C. Two milliliters of cell suspension were com-44 MAP kinase is not a target for activation following
bined with 2 mL of 10% trichloroacetic acid (TCA) andoxalate exposure.
acid insoluble material was collected on Whatman glass
fiber filters. Filters were air-dried and counted in 5 mL
of Optifluor scintillation fluid.METHODS
Materials Western blot analysis
Dulbecco’s modified Eagle’s medium (DMEM), EGF, The cells were washed with ice-cold PBS and solubi-
fetal bovine serum (FBS), penicillin/streptomycin, myelin lized with lysis buffer [20 mmol/L Tris (pH 7.4), 1% Tri-
basic protein (MBP), insulin, and PDGF were purchased ton X-100, 1 mmol/L sodium orthovanadate, 10 mmol/L
from Life Technologies, Inc. (Rockville, MD, USA). ERK sodium fluoride, 1 mmol/L ethylenediaminetetraacetic
(pan-ERK) and ERK1 antibodies (catalogue #E17120 and acid (EDTA), 1 mmol/L phenylmethylsulphonyl fluoride
M12320, respectively) were obtained from BD Transduc- (PMSF), 2 g/mL leupeptin, and 2 g/mL apoprotinin].
tion Laboratories (Los Angles, CA, USA). Goat anti- Lysates were sonicated for one second and centrifuged at
rabbit IgGs, and goat anti-mouse IgGs were obtained 14,000  g at 4C for 15 minutes to remove the insoluble
from Kodak Biolabs Scientific Imaging systems (Roches- material. Gel samples were prepared by adding 2 sam-
ter, NY, USA). Recombinant protein-A agarose, actino- ple buffer [50 mmol/L Tris (pH 6.7), 2% sodium dodecyl
mycin (Ac), and cycloheximide (CHX) were purchased sulfate (SDS), 2% -mercaptoethanol and bromophenol
from Sigma Chemical Co. (St. Louis, MO, USA). Thymi- blue] and boiling for two minutes. Proteins were fraction-
dine [methyl-3H], and adenosine 5-triphosphate [-32P] ated by SDS-polyacrylamide gel electrophoresis (SDS-
ATP was obtained from ICN Radiochemicals, Inc. (Costa PAGE) and transferred to an immobilon-P membrane
Mesa, CA, USA). All other chemicals were analytical using standard electroblotting procedures. Immobilon-P
membranes were blocked with 2% blocking solutiongrade and were obtained from Sigma Chemical Co.
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Fig. 1. Effect of the inhibition of transcription
and translation on oxalate-induced re-initiation
of the DNA synthesis. For these studies, quies-
cent, serum-starved growth-arrested LLC-PK1
cells were exposed to oxalate (1 mmol/L) for
24 hours. Cells were pre-incubated with either
the transcription inhibitor, actinomycin D (A),
or the protein translation inhibitor, cyclohexi-
mide (B), for two hours prior to the addition
of oxalate. Please note that pre-incubation of
the cells with either cycloheximide or actino-
mycin-D inhibited the oxalate-induced re-ini-
tiation of the DNA synthesis. Each data point
is a mean  SD of four to six replicates from
a representative experiment. *P  0.001 vs.
control; a P  0.001 vs. oxalate treated cells.
(Kodak) in Tris (pH 7.2) buffered saline (140 mmol/L action consisted of kinase buffer supplemented with 10
mol/L ATP containing 20 Ci of [-32P] ATP and 10 gNaCl) containing 0.1% Tween-20 (TBST).
Blots were immunolabeled overnight at 4C with pan- of MBP in a final volume of 50 L. The reactions were
carried out at 30C for 20 minutes with shaking. Reac-ERK monoclonal antibody that recognizes several mem-
bers of the ERK family, including p42/44 (1:1000). Immu- tions were stopped by two minutes of centrifugation at
14,000  g and the supernatant was suspended in 2noblots were washed with several changes of TBST at
room temperature and then incubated with anti-mouse Laemmli SDS-sample buffer containing -mercaptoeth-
anol and bromophenol blue. Samples were boiled forIgG linked to horseradish peroxidase or anti-rabbit IgG
linked to horseradish peroxidase. Immunoreactivity was two minutes and run on 12% SDS-polyacrylamide gels.
Immunoprecipitated samples were analyzed by Westerndetected with enhanced chemiluminescence detection
system (Kodak) according to the manufacturer’s recom- blot to ensure that they contained comparable levels of
total ERK protein. Kinase activity was measured by asmended protocol, and then was quantified using densito-
metric analysis (Eagle Eye gel documentation system; the amount of 32P incorporation into specific substrate
proteins (MBP).Stratagene, La Jolla, CA, USA).
Immunocomplex kinase assays Statistical analysis
Statistical analysis was performed using the StudentTo perform these assays, the cells were solubilized with
lysis buffer [20 mmol/L Tris (pH 7.4), 1% Triton X-100, t test.
10% glycerol, 137 mmol/L NaCl, 2 mmol/L EDTA, 25
mmol/L -glycerophosphate, 1 mmol/L sodium orthovan-
RESULTS
adate, 2 mmol/L pyrophosphate, 1 mmol/L PMSF, 1g/mL
Effect of the inhibition of transcription and translationleupeptin] and centrifuged at 14,000  g for 15 minutes
on oxalate induced re-initiation of the DNA synthesisat 4C. Immunoprecipitation of MAP kinase was achieved
by adding 0.5g of anti-ERK antibody, which recognizes These studies examined the requirement of transcrip-
tion as well as translation process in oxalate-induced re-both ERK1 and ERK2, to the cell lysate containing
500 g of total cellular protein, and it was rocked at 4C initiation of the DNA synthesis. For these studies, qui-
escent, serum-starved growth-arrested LLC-PK1 cellsfor two to four hours. Fifty microliters of a 10% wt/vol
suspension of recombinant protein A-agarose beads were were pre-exposed DMEM alone or to either actinomy-
cin-D (a selective inhibitor of transcription, that is, genethen added, and the reaction slurry was allowed to rock
at 4C for 8 to 12 hours. The immunoprecipitation com- expression) or cycloheximide (a selective inhibitor of
translation, that is, protein synthesis) for two hours.plex was washed three times with 0.5 mL of ice-cold lysis
buffer and twice with kinase assay buffer [25 mmol/L These cells were then exposed to oxalate (1 mmol/L) for
an additional 24 hours and pulsed with [3H]-thymidineHEPES (pH 7.4), 25 mmol/L -glycerophosphate, 25
mmol/L MgCl2, 0.1 mmol/L sodium orthovanadate, and during last six hours of incubation. DNA synthesis was
measured as described in the Methods section. Figure 11 mmol/L dithiothreitol (DTT)]. The kinase assay re-
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Fig. 2. Oxalate, epidermal growth factor (EGF) and insulin, but not
platelet-derived growth factor (PDGF), promote re-initiation of the
DNA synthesis in LLC-PK1 cells. For these experiments, quiescent,
Fig. 3. Effects of EGF, PDGF and insulin on oxalate-induced re-initia-serum-starved growth-arrested LLC-PK1 cells were exposed to oxalate
tion of the DNA synthesis. For these experiments, quiescent, serum-(1 mmol/L), EGF (50 ng/mL), PDGF (50 ng/mL) or insulin (100 ng/
starved growth-arrested LLC-PK1 cells were exposed to oxalatemL) for 24 hours, and during the last six hours the cells were exposed
(1 mmol/L) alone or in combination with EGF (50 ng/mL), PDGF (50to [3H]-thymidine (1 to 3 Ci/well). Please note that exposure of cells
ng/mL) or insulin (100 ng/mL) for 24 hours. DNA synthesis was measuredto oxalate, EGF or insulin resulted in re-initiation of the DNA synthesis,
as the amount of 3H-thymidine incorporated into the TCA precipitablewhile exposure to PDGF had no effect. Each data point is a mean 
material. Please note that exposure of the cells to oxalate and EGFSD of six replicates. *P  0.001 vs. control.
together resulted in additive effects on the DNA synthesis, whereas
exposure to oxalate and insulin together had an antagonistic effect on
this process. Each point is a mean  SD of 4 to 6 separate experiments.
*P  0.01 vs. control; a P  0.01 vs. oxalate.
demonstrates that exposure of LLC-PK1 cells to actino-
mycin-D as well as cycloheximide inhibited the effects
of oxalate on re-initiation of the DNA synthesis. These
stimulated DNA synthesis by 2.4- to 3.2-fold, where asdata suggest that new gene expressions as well as protein
EGF increased DNA synthesis by 4- to 5-fold and insulinsynthesis are essential for oxalate-induced re-initiation
stimulated DNA synthesis by 4-fold as compared to theof the DNA synthesis.
control. However, PDGF exposure had no effect on the
Oxalate, EGF and insulin, but not PDGF, promotes re-initiation of the DNA synthesis. The relative sensitiv-
re-initiation of the DNA synthesis in LLC-PK1 cells ity to insulin, EGF and 10% FCS, and oxalate demon-
strates that EGF is most potent stimulator of DNA syn-Previous studies demonstrated that oxalate exposure
thesis for these cells. This sensitivity to EGF and insulinto serum-starved growth-arrested LLC-PK1 cells resulted
suggests that these cells express functional receptors forin a time and concentration dependent re-initiation of
these growth factors and are capable of utilizing thethe DNA synthesis. Also, the effects of oxalate on the re-
p42/44 MAP kinase pathway.initiation of the DNA synthesis were comparable to
those of FCS (10%), raising the possibility that these
Effects of EGF, PDGF and insulin on oxalate-inducedeffects of oxalate may involve activation of p42/44 MAP
re-initiation of DNA synthesiskinase pathway. To evaluate this possibility, present
After establishing that EGF as well as insulin are inde-studies examined the effect of oxalate or three other
pendently capable of re-initiating DNA synthesis inwell-characterized growth factors (that are known to ac-
growth-arrested LLC-PK1 cells, their effects were evalu-tivate p42/44 MAP kinase pathway), EGF, insulin or
ated on oxalate-induced re-initiation of DNA synthesis.PDGF on re-initiation of DNA synthesis in quiescent,
As shown in Figure 3, there was a complete dichotomyserum-starved growth-arrested LLC-PK1 cells. Data
when oxalate was added in combination with EGF orpresented from a representative experiment (Fig. 2),
insulin. On one hand, the addition of EGF further stimu-show that exposure of LLC-PK1 to oxalate, EGF or
lated the effects of oxalate on DNA synthesis. Quantita-insulin resulted in the re-initiation of the DNA synthesis.
tive analysis demonstrated that combination of EGF andAt least 4 to 12 similar independent experiments with
four to six replicates were carried out. Oxalate exposure oxalate increased DNA synthesis more than 100% of
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Fig. 4. Western blot analysis. Confluent mono-
layers of LLC-PK1 cells were serum-starved
and growth-arrested before being exposed to
oxalate (1 mmol/L; A), or EGF (50 ng/mL)
alone (B), or a combination of EGF (50 ng/
mL) and oxalate (1 mmol/L; C) for various
time periods. At the end of the experimental
period, cells were lysed and protein extracts
(100 g/well) were fractionated on SDS-poly-
acrylamide gels (10%), transferred to immobi-
lon-P membranes, and analyzed by Western
blot analysis using a pan-ERK monoclonal
antibody comprised of several members of the
ERK family. Please note that oxalate expo-
sure had no effect on ERK2 or p85 mobility,
where as EGF exposure resulted in a rapid
and reversible phosphorylation as measured
by decrease in mobility of ERK2, and simulta-
neous addition of oxalate and EGF neither
increased nor attenuated the effect of EGF.
the total stimulation than when oxalate or EGF was mobility. Maximum activation, as determined by maxi-
mum protein retardation, occurred at 15 minutes. How-added alone, suggesting somewhat synergistic effects. On
the other hand, the addition of a combination of insulin ever, exposure of cells to oxalate had no effect on activa-
tion/phosphorylation of ERK-2 MAP kinase (Fig. 4A).and oxalate resulted in a complete attenuation of DNA
synthesis. These results are somewhat surprising, since Furthermore, exposure of cells to oxalate and EGF to-
gether did not increase the extent or duration of phos-both EGF and insulin utilize the ERK1/ERK2 MAP
kinase pathway. Nonetheless, these data suggest that the phorylation of ERK-2 MAP kinase (Fig. 4C). Since it is
well established that the activity of MAP kinases de-effects of oxalate on the DNA synthesis involve signaling
pathways that are distinct from those of EGF and insulin. pends on the phosphorylation state of the enzyme, these
data demonstrate that oxalate does not affect the ERK-
Effects of oxalate and EGF on the activation of MAP kinase activity.
ERK/MAP kinase To further characterize the effects of oxalate on ERK-1/
ERK-2 MAP kinase enzyme activity, LLC-PK1 cellsThese experiments directly measured the effects of
oxalate alone, EGF alone, or a combination of EGF and were exposed to DMEM alone or in combination with
oxalate (1 mmol/L) for various time points (0 to 30 min)oxalate on ERK activation. For these studies, quiescent
cultures of LLC-PK1 cells were serum-starved and growth- or EGF (50 ng/mL) for 30 minutes. ERK-1/ERK-2 MAP
kinase was then immunoprecipitated with an antibodyarrested overnight. These cells were exposed to either
oxalate (1 mmol/L) or EGF (50 ng/mL), or a combination that recognizes total ERK-1/ERK-2 MAP kinase (phos-
phorylated as well as unphosphorylated), and an immu-of oxalate (1 mmol/L) and EGF (50 ng/mL) for various
time points (0, 15, 30, 60, 120 and 240 min). At the end nocomplex kinase assay was performed as described in
the Methods section. As shown in Figure 5A, exposureof experimental period, media were aspirated. The cells
were washed with ice-cold PBS and processed for ERK to oxalate had no effect on ERK-1/ERK-2 MAP kinase
activity. EGF (50 ng/mL) robustly stimulated ERK-1/analysis by Western blot analysis as described in the
Methods section. The results demonstrate that exposure ERK-2 MAP kinase activity. Western blot analysis of
the immunoprecipitated material (Fig. 5B) demonstratedof cells to EGF resulted in rapid and reversible phos-
phorylation of ERK-2 MAP kinase, as seen by slower equal immunoprecipitation of ERK between the various
groups. Immunocomplex kinase data from three separatemobility of ERK2 in Figure 4B. Activation of ERK by
phosphorylation caused a retardation in electrophoretic experiments were analyzed and quantitated further, and
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ERK-1/ERK-2 MAP kinase is not a target for activation
following oxalate exposure to LLC-PK1 cells.
DISCUSSION
The present study on renal epithelial cells, with charac-
teristics of the S1-S3 segment of the proximal tubule,
is the first direct demonstration of the requirement of
translation/transcription for oxalate-induced re-initia-
tion of the DNA synthesis. This study also provides the
first direct evidence of additive effects of oxalate and
EGF and antagonistic effects of oxalate and insulin on
the DNA synthesis. The conclusion that effects of oxalate
do not involve activation of p42/44 MAP-kinase pathway
is supported by several lines of evidence, for example, the
additive effects of oxalate and EGF on DNA synthesis in
growth arrested cells suggest involvement of separate
pathways. Antagonistic effects of oxalate and insulin fur-
ther substantiate this notion. In addition to these indirect
indicators, the direct measurement of phosphorylation
as well as activity of p42/44 MAP kinase clearly demon-
strated lack of the effect of oxalate on this pathway.
Previous studies have shown that exposure of LLC-
PK1 cells to oxalate resulted in a re-initiation of the
DNA synthesis as measured by [3H]-thymidine incorpo-
ration into the TCA precipitable material [10]. Results
from our present study demonstrate that transcription/
translation inhibitors were able to inhibit this process.
These data demonstrate that the oxalate stimulated re-
initiation of the DNA synthesis in growth-arrested LLC-
PK1 cells requires new gene expression as well as new
protein synthesis. It is important to point out that addi-
Fig. 5. Lack of the effect of oxalate on ERK-1/ERK-2 MAP kinase
tional studies from our laboratory have shown that pre-activity. For these experiments, growth-arrested LLC-PK1 cells were
exposed to oxalate (1 mmol/L) for various time points or to EGF for treatment of cells with aphidicolin (a specific inhibitor
30 minutes. At the end of the experimental period, cells were lysed by of DNA polymerase 	) abolished this oxalate-induced
the addition of lysis buffer (20 mmol/L Tris, pH 7.4, 1% Triton X-100,
[3H]-thymidine incorporation (unpublished observations).10% glycerol, 137 mmol/L NaCl, 2 mmol/L EDTA, 25 mmol/L -glyc-
erophosphate, 1 mmol/L sodium orthovanadate, 2 mmol/L pyrophos- These results demonstrated that the oxalate-induced re-
phate, 1 mmol/L PMSF, 10 g/mL leupeptin) and centrifuged at initiation of DNA synthesis is dependent on the activity14,000  g for 15 minutes at 4C. Kinase activity was determined in
of active DNA polymerase 	. These findings furthercell extracts by immunocomplex kinase assay using myelin basic protein
(MBP) as the substrate. Proteins were separated on 12% SDS-PAGE. strengthen the notion that re-initiation of the DNA syn-
Data are shown as (A) autoradiograph; (B) Western blot analysis of thesis following oxalate exposure is not a random event,immunoprecipitated material; and (C ) quantitative analysis of the ex-
but an organized process that involves both new genetent of phosphorylation of MBP. Please note that exposure to oxalate
had no effect on the MBP phosphorylation; **P  0.001 vs. control. expression and protein synthesis.
A majority of the agents that promote cell growth
or death also influence cellular function by activating
cascades of protein phosphorylation reactions, collec-the results are presented in Figure 5C. These data demon-
tively referred to as MAP kinases. MAP kinases havestrate that exposure to oxalate resulted in a mild but a
provided a focal point for remarkably rapid advances innon-significant increase (9646.333  1217 vs. 13328.67 
our understanding of the control of cellular events by2291.664, control vs. 30-min oxalate exposure) in ERK-1/
growth factors and cytokines [34]. To date over a dozenERK-2 enzyme activity. However, exposure of LLC-PK1
MAP kinase family members have been discovered.cells to EGF resulted in a significant (P 0.001) increase
Each cascade consists of no fewer than three enzymesin ERK1/ERK2 enzyme activity (9646.333  1217 vs.
that are activated in series. The type of three-kinase44954.33 772.0728, control vs. EGF; a 4.6-fold increase,
regulatory cascade not only conveys information to theP  0.001) as compared to control cells. Based on these
data and the data presented in Figure 4, we conclude that target effectors, but also coordinates incoming informa-
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tion from parallel signaling pathways, which allows for
signal amplification, generates a threshold and a sigmoi-
dal activation profile, is subject to multiple activation
mechanisms, and accommodates a variety of mechanisms
to control subcellular localization [reviewed in 35]. These
enzymes help mediate diverse processes ranging from
transcription of protooncogenes to programmed cell
death. The most extensively studied MAP kinases are
classical p42/44 MAP kinase, also known as ERK-1/
ERK-2 MAP kinase. EGF, PDGF and insulin have been
documented to activate this signaling cascade. Our re-
sults demonstrate that only EGF and insulin stimulated
a re-initiation of the DNA synthesis in LLC-PK1 cells,
while PDGF had no effect on this process. These data
suggest that LLC-PK1 cells may lack PDGF receptors.
We also observed a dichotomy in the effects of oxalate
when added in combination with either insulin or EGF.
Our results demonstrate that the effects of oxalate and
EGF on DNA synthesis are additive, while the effects
of oxalate and insulin are antagonistic. While both insulin
and EGF activate the p42/44 MAP kinase pathway, how
Fig. 6. Proposed cross-talk between signal transduction pathways acti-
could effects of oxalate be additive in one case and inhibi- vated by insulin and oxalate showing that individually, oxalate, EGF
as well as insulin stimulate DNA synthesis. The effects of oxalate andtory in another case? The mechanisms regulating p42/44
EGF on DNA synthesis are additive, while the effects of oxalate andMAP kinase activity have been extensively studied. It
insulin are antagonistic. Insulin and EGF both activate the p42/44 MAP
has been shown that ligands stimulate receptor tyrosine kinase pathway. Thus, for oxalate and insulin to cancel each other’s
effect on DNA synthesis, cross talk has to occur between oxalate or thekinase activity, which leads to enhanced tyrosine kinase
oxalate-stimulated signaling pathway and insulin-stimulated signalingautophosphorylation. Adapter molecules containing SH2
pathway up-stream of common shared elements in EGF and insulin-
domains bind to the receptors and through a series of stimulated signaling pathways.
intermediate molecules (sos, ras, raf) transmit signals to
the dual-specificity protein kinases MEK1 and MEK2
[36–39]. MEK1 and MEK2 are the direct activators of oxalate in combination of EGF did not increase the
p42/44 MAP kinase. While it is well established that the amount of the p42/44 MAP kinase activity or even the
action of EGF, insulin and PDGF is mediated by the duration of p42/44 MAP kinase activity. These data dem-
activation of this central pathway, it is important to point onstrate that p42/44 MAP kinase is not the target of acti-
out that several alternating pathways have been shown vation following oxalate exposure, suggesting that addi-
to converge on to p42/44 MAP kinase. While activation tional signaling pathways may be involved. Interestingly,
of p42/44 MAP kinase by some agents may require pro- p42/44 MAP kinases are activated by mitogens and a
tein kinase C (PKC) activation [40], in other cases deple- common view is that they are essentially shared elements
tion of PKC has been shown to stimulate p42/44 MAP in mitogenic signaling. The facts that oxalate (a meta-
kinase [41, 42]. The phosphorylation cascade from insu- bolic end product) induced a re-initiation of the DNA
lin receptor to the p42/44 MAP kinase differs from the synthesis without affecting the p42/44 MAP kinase path-
phosphorylation cascade from EGF receptor to the p42/ way adds a new dimension to this concept. Indeed, sev-
44 MAP kinase. Thus, the dichotomy in the effects of eral other recent studies have demonstrated that DNA
oxalate on EGF and insulin stimulated pathways may be synthesis can occur independently of p42/44 MAP kinase
explained by the differences in the pathways upstream of activation [43–46]. It is interesting to point out here that
p42/44 MAP kinase that are activated by either EGF recently PLA2 activation has been suggested to mediate
or insulin. Furthermore, these data suggest a cross-talk oxalate toxicity and early growth responsive gene acti-
between oxalate or oxalate stimulated signaling pathways vation in Madin-Darby canine kidney (MDCK) cells
and the insulin stimulated signaling pathway upstream [47, 48], which raises the possibility that similar mecha-
of ERK1/ERK2. Based on these studies, we propose a nisms may be activated in LLC-PK1 cells. However, de-
hypothetical model of cross-talk between oxalate and spite PLA2 activation, oxalate exposure does not result
insulin-stimulated signal transduction pathways (Fig. 6). in DNA synthesis in MDCK cells [14]. Clearly, additional
Our results also demonstrate that oxalate had no direct studies are required to evaluate the exact signal transduc-
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